Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7368389, 13 pages
http://dx.doi.org/10.1155/2016/7368389
Research Article

Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy

1Multidisciplinary Department of Medical-Surgical and Dental Specialties, Second University of Naples, 80138 Naples, Italy
2Department of Experimental Medicine, Second University of Naples, 80138 Naples, Italy
3Department of Clinical, Public and Preventive Medicine, Second University of Naples, 80138 Naples, Italy
4The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London EC1M 6BQ, UK
5Faculty of Science and Technology, Department of Life Sciences, University of Westminster, London W1W 6UW, UK
6Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy
7Pharmacy Department, University of Naples Federico II, 80131 Naples, Italy

Received 2 October 2015; Revised 1 December 2015; Accepted 15 December 2015

Academic Editor: Elaine Hatanaka

Copyright © 2016 S. Rossi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Cai and M. Boulton, “The pathogenesis of diabetic retinopathy: old concepts and new questions,” Eye, vol. 16, no. 3, pp. 242–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Archer, “Bowman lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations,” Eye, vol. 13, no. 4, pp. 497–523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar
  4. N. H. White, W. Sun, P. A. Cleary et al., “Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial,” Archives of Ophthalmology, vol. 126, no. 12, pp. 1707–1715, 2008. View at Publisher · View at Google Scholar
  5. S. K. Manna and B. B. Aggarwal, “α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents,” The Journal of Immunology, vol. 161, no. 6, pp. 2873–2880, 1998. View at Google Scholar · View at Scopus
  6. L. W. Martin, A. Catania, M. E. Hiltz, and J. M. Lipton, “Neuropeptide α-MSH antagonizes IL-6- and TNF-induced fever,” Peptides, vol. 12, no. 2, pp. 297–299, 1991. View at Publisher · View at Google Scholar
  7. R. S. Bhardwaj, A. Schwarz, E. Becher et al., “Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes 1,” Journal of Immunology, vol. 156, no. 7, pp. 2517–2521, 1996. View at Google Scholar · View at Scopus
  8. P. Redondo, J. García-Foncillas, I. Okroujnov, and E. Bandrés, “α-MSH regulates interleukin-10 expression by human keratinocytes,” Archives of Dermatological Research, vol. 290, no. 8, pp. 425–428, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Grabbe, R. S. Bhardwaj, K. Mahnke, M. M. Simon, T. Schwarz, and T. A. Luger, “α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice,” Journal of Immunology, vol. 156, no. 2, pp. 473–478, 1996. View at Google Scholar · View at Scopus
  10. A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon, “Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress,” Physiological Reviews, vol. 80, no. 3, pp. 979–1020, 2000. View at Google Scholar · View at Scopus
  11. T. E. Scholzen, C. Sunderkötter, D.-H. Kalden et al., “α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression,” Endocrinology, vol. 144, no. 1, pp. 360–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Raap, T. Brzoska, S. Sohl et al., “α-melanocyte-stimulating hormone inhibits allergic airway inflammation,” The Journal of Immunology, vol. 171, no. 1, pp. 353–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. L. F. Chan, L. A. Metherell, and A. J. L. Clark, “Effects of melanocortins on adrenal gland physiology,” European Journal of Pharmacology, vol. 660, no. 1, pp. 171–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Lindqvist, U. Näpänkangas, J. Lindblom, and F. Hallböök, “Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection,” European Journal of Pharmacology, vol. 482, no. 1–3, pp. 85–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-S. Cui, S. Hayasaka, X.-Y. Zhang, Z.-L. Chi, and Y. Hayasaka, “Effect of alpha-melanocyte-stimulating hormone on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line,” Ophthalmic Research, vol. 37, no. 5, pp. 279–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Grässel, A. Opolka, S. Anders et al., “The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of α-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components,” Arthritis & Rheumatism, vol. 60, no. 10, pp. 3017–3027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. F. L. Strand, “New vistas for melanocortins. Finally, an explanation for their pleiotropic functions,” Annals of the New York Academy of Sciences, vol. 897, pp. 1–16, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. W. Taylor and D. Lee, “Applications of the role of α-MSH in ocular immune privilege,” in Melanocortins: Multiple Actions and Therapeutic Potential, vol. 681 of Advances in Experimental Medicine and Biology, pp. 143–149, Springer, New York, NY, USA, 2010. View at Publisher · View at Google Scholar
  19. N. Naveh, “Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 241, no. 12, pp. 1044–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Edling, D. Gomes, T. Weeden et al., “Immunosuppressive activity of a novel peptide analog of α-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis,” Journal of Neuroimmunology, vol. 236, no. 1-2, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Zhang, L. Dong, X. Liu et al., “α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes,” PLoS ONE, vol. 9, no. 4, Article ID e93433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L.-B. Cheng, L. Cheng, H.-E. Bi et al., “Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling,” Biochemical and Biophysical Research Communications, vol. 443, no. 2, pp. 447–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X.-X. Zeng, Y.-K. Ng, and E.-A. Ling, “Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats,” Visual Neuroscience, vol. 17, no. 3, pp. 463–471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Leoni, M. B. Voisin, K. Carlson, S. Getting, S. Nourshargh, and M. Perretti, “The melanocortin MC1 receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature,” British Journal of Pharmacology, vol. 160, no. 1, pp. 171–180, 2010. View at Publisher · View at Google Scholar
  25. S. J. Getting, C. Di Filippo, H. C. Christian et al., “MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct,” Journal of Leukocyte Biology, vol. 76, no. 4, pp. 845–853, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Grieco, G. Han, D. Weinberg, T. MacNeil, L. H. T. Van der Ploeg, and V. J. Hruby, “Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6,” Biochemical and Biophysical Research Communications, vol. 292, no. 4, pp. 1075–1080, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Getting, C. W. Lam, G. Leoni, F. N. E. Gavins, P. Grieco, and M. Perretti, “[D-Trp8]-γ-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse),” Molecular Pharmacology, vol. 70, no. 6, pp. 1850–1855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Grieco, M. Cai, L. Liu et al., “Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists,” Journal of Medicinal Chemistry, vol. 51, no. 9, pp. 2701–2707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. L. Møller, K. Raun, M. L. Jacobsen et al., “Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved,” Molecular and Cellular Endocrinology, vol. 341, no. 1-2, pp. 9–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Di Filippo, C. Rossi, B. Ferraro et al., “Involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty rats with metabolic syndrome,” Mediators of Inflammation, vol. 2014, Article ID 972761, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Di Filippo, M. V. Zippo, R. Maisto et al., “Inhibition of ocular aldose reductase by a new benzofuroxane derivative ameliorates rat endotoxic uveitis,” Mediators of Inflammation, vol. 2014, Article ID 857958, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Moreno, M. Lozano, and P. Salinas, “Diabetic retinopathy,” Nutricion Hospitalaria, vol. 28, no. 2, pp. 53–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. L. Engerman and T. S. Kern, “Retinopathy in animal models of diabetes,” Diabetes/Metabolism Reviews, vol. 11, no. 2, pp. 109–120, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. D.-Y. Yu, S. J. Cringle, E.-N. Su, P. K. Yu, G. Jerums, and M. E. Cooper, “Pathogenesis and intervention strategies in diabetic retinopathy,” Clinical and Experimental Ophthalmology, vol. 29, no. 3, pp. 164–166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. R. L. Engerman, “Pathogenesis of diabetic retinopathy,” Diabetes, vol. 38, no. 10, pp. 1203–1206, 1989. View at Publisher · View at Google Scholar · View at Scopus
  37. A. J. Barber, “A new view of diabetic retinopathy: a neurodegenerative disease of the eye,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 2, pp. 283–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Rungger-Brändle, A. A. Dosso, and P. M. Leuenberger, “Glial reactivity, an early feature of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 41, no. 7, pp. 1971–1980, 2000. View at Google Scholar · View at Scopus
  39. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Watanabe, K. Suzuma, I. Suzuma et al., “Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 139, no. 3, pp. 476–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. F. Kador, P. Zhang, J. Makita et al., “Novel diabetic mouse models as tools for investigating diabetic retinopathy,” PLoS ONE, vol. 7, no. 12, Article ID e49422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Villacampa, A. Ribera, S. Motas et al., “Insulin-like growth factor I (IGF-I)-induced chronic gliosis and retinal stress lead to neurodegeneration in a mouse model of retinopathy,” The Journal of Biological Chemistry, vol. 288, no. 24, pp. 17631–17642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. K. Kaneva, M. J. P. Kerrigan, P. Grieco, G. P. Curley, I. C. Locke, and S. J. Getting, “Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes,” British Journal of Pharmacology, vol. 167, no. 1, pp. 67–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. M. K. Kaneva, M. J. P. Kerrigan, P. Grieco, G. P. Curley, I. C. Locke, and S. J. Getting, “Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury,” Biochemical Pharmacology, vol. 92, no. 2, pp. 336–347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Montero-Melendez, T. Gobbetti, S. N. Cooray, T. E. Jonassen, and M. Perretti, “Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects,” The Journal of Immunology, vol. 194, no. 7, pp. 3381–3388, 2015. View at Publisher · View at Google Scholar
  46. J. Deng, X. Hu, P. S. T. Yuen, and R. A. Star, “α-Melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 6, pp. 749–756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Ceriani, J. Diaz, S. Murphree, A. Catania, and J. M. Lipton, “The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats,” Neuroimmunomodulation, vol. 1, no. 1, pp. 28–32, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. D. J. Lee, D. J. Biros, and A. W. Taylor, “Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis,” International Immunopharmacology, vol. 9, no. 9, pp. 1079–1086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Rigamonti, P. Zordan, C. Sciorati, P. Rovere-Querini, and S. Brunelli, “Macrophage plasticity in skeletal muscle repair,” BioMed Research International, vol. 2014, Article ID 560629, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. M. J. Davis, T. M. Tsang, Y. Qiu et al., “Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection,” mBio, vol. 4, no. 3, Article ID e00264-13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Jadhav, S. Tiwari, P. Lee, and J. F. Ndisang, “The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in zucker diabetic fatty rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 345, no. 2, pp. 239–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. T. J. Ahmed, T. Montero-Melendez, M. Perretti, and C. Pitzalis, “Curbing inflammation through endogenous pathways: focus on melanocortin peptides,” International Journal of Inflammation, vol. 2013, Article ID 985815, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Montero-Melendez, “ACTH: the forgotten therapy,” Seminars in Immunology, vol. 27, no. 3, pp. 216–226, 2015. View at Publisher · View at Google Scholar